sur Bayer Aktiengesellschaft (ETR:BAYN)
Monsanto Announces Roundup™ Class Settlement Agreement
On February 17, 2026, Monsanto, a subsidiary of Bayer Aktiengesellschaft, announced a proposed U.S. nationwide class settlement for Roundup™ litigation. The settlement, totaling up to 7.25 billion USD, aims to resolve existing and future claims alleging Non-Hodgkin lymphoma injuries linked to Roundup™ exposure. Court approval is required for this settlement, which is part of a broader strategy addressing legal challenges.
Monsanto plans annual payments over 21 years, providing financial predictability. Concurrently, the company has settled other cases, including PCB-related verdicts. These legal measures will increase Bayer's litigation liabilities from 7.8 billion euros to 11.8 billion euros, with a forecasted negative cash flow in 2026.
Despite these settlements, Monsanto denies any liability. The strategy includes obtaining regulatory clarity and minimizing litigation risks, with an anticipated U.S. Supreme Court review playing a critical role.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Bayer Aktiengesellschaft